Coronary heart disease, stroke, diabetes and hypertension patients. Number of cardiovascular events prevented by improving control of blood pressure and cholesterol
| Condition/intervention | Sex | Age group | Current % of patients within target level | Baseline risk of CVD event | Reduction in number of CVD events (n) |
|---|---|---|---|---|---|
| CHD = coronary heart disease; CVD = cardiovascular disease. | |||||
| CHD/blood pressure lowering treatment | M | 45–64 | 73% | 12.8% | 0.00 |
| 65–84 | 62% | 30.0% | 2.37 | ||
| F | 45–64 | 74% | 6.6% | 0.00 | |
| 65–84 | 59% | 18.2% | 1.21 | ||
| CHD/cholesterol lowering treatment | M | 45–64 | 25% | 12.8% | 3.20 |
| 65–84 | 29% | 30.0% | 5.91 | ||
| F | 45–64 | 21% | 6.6% | 0.88 | |
| 65–84 | 10% | 18.2% | 5.47 | ||
| Stroke/blood pressure lowering treatment | M | 45–64 | 56% | 17.0% | 0.27 |
| 65–84 | 49% | 40.0% | 1.54 | ||
| F | 45–64 | 79% | 8.8% | 0.00 | |
| 65–84 | 51% | 24.2% | 1.08 | ||
| Stroke/cholesterol lowering treatment | M | 45–64 | 26% | 17.0% | 1.25 |
| 65–84 | 33% | 40.0% | 3.59 | ||
| F | 45–64 | 27% | 8.8% | 0.44 | |
| 65–84 | 11% | 24.2% | 1.94 | ||
| Diabetes/blood pressure lowering treatment | M | 45–64 | 43% | 18.0% | 0.55 |
| 65–84 | 46% | 28.6% | 1.11 | ||
| F | 45–64 | 48% | 14.3% | 0.27 | |
| 65–84 | 29% | 23.5% | 0.99 | ||
| Diabetes/cholesterol lowering treatment | M | 45–64 | 32% | 18.0% | 2.09 |
| 65–84 | 45% | 28.6% | 1.95 | ||
| F | 45–64 | 20% | 14.3% | 0.94 | |
| 65–84 | 17% | 23.5% | 1.54 | ||
| Hypertension/blood pressure lowering treatment | M | 45–64 | 54% | 10.6% | 5.00 |
| 65–84 | 29% | 21.0% | 3.40 | ||
| F | 45–64 | 58% | 6.3% | 2.41 | |
| 65–84 | 34% | 13.1% | 4.64 | ||